{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:03:25Z","timestamp":1792533805527,"version":"4.5.0"},"reference-count":50,"publisher":"The Journal of Rheumatology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess health- and patient-centered outcomes in gout across Europe, and explore patient-, care-, and country-level characteristics associated with these outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with self-reported physician-diagnosed gout from 14 European countries completed an online survey. Multivariable mixed-effect logistic and linear regressions were computed for health outcomes (gout flare recurrence) and patient-centered outcomes (patient satisfaction with current medication, and unaddressed goals), accounting for clustering within countries. The role of patient-, care-, and country-level factors was explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants included 1029 patients, predominantly diagnosed by a general practitioner (GP). One or more gout flares were reported by 70% of patients and \u2265 3 flares by 32%. Gout patients reported 1.1 \u00b1 1.2 unaddressed goals, and 80% were satisfied with current medication. Patients with \u2265 3 and \u2265 1 flares were less likely to be treated with urate-lowering therapy (ULT) (OR 0.52, 95% CI 0.39\u20130.70 and OR 0.38, 95% CI 0.28\u20130.53, respectively), but more likely to have regular physician visits (OR 2.40, 95% CI 1.79\u20133.22 and OR 1.77, 95% CI 1.30\u20132.41). Three or more gout flares were also associated with lower satisfaction (OR 0.39, 95% CI 0.28\u20130.56) and more unaddressed goals (\u03b2 0.36, 95% CI 0.19\u20130.53). Notwithstanding, the predicted probability of being satisfied was still between 57% and 75% among patients with \u2265 3 flares but who were not receiving ULT. Finally, patients from wealthier and Northern European countries more frequently had \u2265 3 gout flares.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Across Europe, many patients with gout remain untreated despite frequent reported flares. Remarkably, a substantial proportion of them were still satisfied with gout management. A better understanding of patients\u2019 satisfaction and its role in physicians\u2019 gout management decisions is warranted to improve quality of care and gout outcomes across Europe.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.210009","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T12:35:19Z","timestamp":1623760519000},"page":"312-319","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of Care Among Patients With Gout in Europe: A Cross-sectional Survey"],"prefix":"10.3899","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-1444","authenticated-orcid":false,"given":"Ritch","family":"te Kampe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3026-3154","authenticated-orcid":false,"given":"Tim L.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"van Durme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-6257","authenticated-orcid":false,"given":"Matthijs","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudula","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-9533","authenticated-orcid":false,"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"2022062202300624000_49.3.312.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.91"},{"key":"2022062202300624000_49.3.312.2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2022062202300624000_49.3.312.3","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-10-117"},{"key":"2022062202300624000_49.3.312.4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/BOR.0000000000000583","article-title":"Patient perspectives in gout: a review","volume":"31","author":"Singh","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"2022062202300624000_49.3.312.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-009-0022-4"},{"key":"2022062202300624000_49.3.312.6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00296-017-3777-3","article-title":"Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients","volume":"37","author":"Janssen","year":"2017","journal-title":"Rheumatol Int"},{"key":"2022062202300624000_49.3.312.7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12882-019-1274-5","article-title":"Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population","volume":"20","author":"Singh","year":"2019","journal-title":"BMC Nephrol"},{"key":"2022062202300624000_49.3.312.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210538"},{"key":"2022062202300624000_49.3.312.9","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/art.39318","article-title":"Gout is a chronic inflammatory disease in which high levels of interleukin-8 (cxcl8), myeloid-related protein 8\/myeloid-related protein 14 complex, and an altered proteome are associated with diabetes mellitus and cardiovascular disease","volume":"67","author":"Kienhorst","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2022062202300624000_49.3.312.10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev030"},{"key":"2022062202300624000_49.3.312.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"2022062202300624000_49.3.312.12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204463"},{"key":"2022062202300624000_49.3.312.13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex530"},{"key":"2022062202300624000_49.3.312.14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq363"},{"key":"2022062202300624000_49.3.312.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32158-5"},{"key":"2022062202300624000_49.3.312.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.076232"},{"key":"2022062202300624000_49.3.312.17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/PROM.S108868","article-title":"Patient considerations in the management of gout and role of combination treatment with lesinurad","volume":"9","author":"Claus","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"key":"2022062202300624000_49.3.312.18","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S162956"},{"key":"2022062202300624000_49.3.312.19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jbspin.2017.03.013","article-title":"Persistent clinical inertia in gout in 2014: an observational French longitudinal patient database study","volume":"85","author":"Maravic","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2022062202300624000_49.3.312.20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40744-017-0091-1","article-title":"Improvement in diagnosis and treat-to-target management of hyperuricemia in gout: results from the GEMA-2 transversal study on practice","volume":"5","author":"Perez Ruiz","year":"2018","journal-title":"Rheumatol Ther"},{"key":"2022062202300624000_49.3.312.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2011.01.028"},{"key":"2022062202300624000_49.3.312.22","doi-asserted-by":"publisher","DOI":"10.1177\/152715440100200312"},{"key":"2022062202300624000_49.3.312.23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/PPA.S81975","article-title":"Measuring the quality of patient-centered care: why patient-reported measures are critical to reliable assessment","volume":"9","author":"Tzelepis","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"2022062202300624000_49.3.312.24","doi-asserted-by":"crossref","first-page":"2333721417700759","DOI":"10.1177\/2333721417700759","article-title":"Patient-centered outcomes research and patient-centered care for older adults: a perspective","volume":"3","author":"Jayadevappa","year":"2017","journal-title":"Gerontol Geriatr Med"},{"key":"2022062202300624000_49.3.312.25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40271-016-0184-x","article-title":"What outcomes are important for gout patients? In-depth qualitative research into the gout patient experience to determine optimal endpoints for evaluating therapeutic interventions","volume":"10","author":"Tatlock","year":"2017","journal-title":"Patient"},{"key":"2022062202300624000_49.3.312.26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2017.12.005","article-title":"Health-related quality of life in gout in primary care: baseline findings from a cohort study","volume":"48","author":"Chandratre","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2022062202300624000_49.3.312.27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/RHU.0000000000000981","article-title":"Patient perceptions of gout management goals: a cross-sectional internet survey","volume":"26","author":"Singh","year":"2020","journal-title":"J Clin Rheumatol"},{"key":"2022062202300624000_49.3.312.28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214259"},{"key":"2022062202300624000_49.3.312.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev395"},{"key":"2022062202300624000_49.3.312.30","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket262"},{"key":"2022062202300624000_49.3.312.31","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen20X101003"},{"key":"2022062202300624000_49.3.312.32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13075-019-1918-7","article-title":"Gout, flares, and allopurinol use: a population-based study","volume":"21","author":"Proudman","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022062202300624000_49.3.312.33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.31128\/AJGP-04-19-4909","article-title":"The challenges of managing gout in primary care: results of a best-practice audit","volume":"48","author":"Stamp","year":"2019","journal-title":"Aust J Gen Pract"},{"key":"2022062202300624000_49.3.312.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1056-7"},{"key":"2022062202300624000_49.3.312.35","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150310"},{"key":"2022062202300624000_49.3.312.36","first-page":"529","article-title":"Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care\u20145-year follow-up of a proof-of-concept study","volume":"56","author":"Abhishek","year":"2017","journal-title":"Rheumatology"},{"key":"2022062202300624000_49.3.312.37","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket158"},{"key":"2022062202300624000_49.3.312.38","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3212-2"},{"key":"2022062202300624000_49.3.312.39","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0570"},{"key":"2022062202300624000_49.3.312.40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jbspin.2015.10.008","article-title":"Gout characteristics associate with depression, but not anxiety, in primary care: baseline findings from a prospective cohort study","volume":"83","author":"Prior","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2022062202300624000_49.3.312.41","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2010.540874"},{"key":"2022062202300624000_49.3.312.42","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S83700"},{"key":"2022062202300624000_49.3.312.43","doi-asserted-by":"publisher","DOI":"10.1177\/1742395310378761"},{"key":"2022062202300624000_49.3.312.44","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/acr.23995","article-title":"Comparative study of real-life management strategies in gout: data from two protocolized gout clinics","volume":"72","author":"Te Kampe","year":"2020","journal-title":"Arthritis Care Res"},{"key":"2022062202300624000_49.3.312.45","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199703)6:2<109::AID-HEC251>3.0.CO;2-L"},{"key":"2022062202300624000_49.3.312.46","doi-asserted-by":"publisher","DOI":"10.1093\/esr\/jcp014"},{"key":"2022062202300624000_49.3.312.47","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-010-0157-3"},{"key":"2022062202300624000_49.3.312.48","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100418"},{"key":"2022062202300624000_49.3.312.49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.40381","article-title":"Brief report: validation of a definition of flare in patients with established gout","volume":"70","author":"Gaffo","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2022062202300624000_49.3.312.50","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/rheumatology\/kez064","article-title":"Development and validation of a patient-reported gout attack intensity score for use in gout clinical studies","volume":"58","author":"Janssen","year":"2019","journal-title":"Rheumatology"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.210009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T09:30:27Z","timestamp":1655890227000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.210009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,1]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.3899\/jrheum.210009"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.210009","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}